tetano
Editor, Senior Moderator
Pathog Dis
. 2021 Jan 9;79(1):ftaa076.
doi: 10.1093/femspd/ftaa076.
Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?-Clues from exotic animal reservoirs
Esaki M Shankar[SUP] 1 [/SUP], Karlhans F Che[SUP] 2 [/SUP], Yean K Yong[SUP] 3 [/SUP], A S Smiline Girija[SUP] 4 [/SUP], Vijayakumar Velu[SUP] 5 6 [/SUP], Abdul W Ansari[SUP] 7 [/SUP], Marie Larsson[SUP] 8 [/SUP]
Affiliations
Abstract
A vast proportion of coronavirus disease 2019 (COVID-19) individuals remain asymptomatic and can shed severe acute respiratory syndrome (SARS-CoV) type 2 virus to transmit the infection, which also explains the exponential increase in the number of COVID-19 cases globally. Furthermore, the rate of recovery from clinical COVID-19 in certain pockets of the globe is surprisingly high. Based on published reports and available literature, here, we speculated a few immunovirological mechanisms as to why a vast majority of individuals remain asymptomatic similar to exotic animal (bats and pangolins) reservoirs that remain refractile to disease development despite carrying a huge load of diverse insidious viral species, and whether such evolutionary advantage would unveil therapeutic strategies against COVID-19 infection in humans. Understanding the unique mechanisms that exotic animal species employ to achieve viral control, as well as inflammatory regulation, appears to hold key clues to the development of therapeutic versatility against COVID-19.
Keywords: COVID-19; SARS-CoV-2; asymptomatic; evolution; monocytes; origin.
. 2021 Jan 9;79(1):ftaa076.
doi: 10.1093/femspd/ftaa076.
Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?-Clues from exotic animal reservoirs
Esaki M Shankar[SUP] 1 [/SUP], Karlhans F Che[SUP] 2 [/SUP], Yean K Yong[SUP] 3 [/SUP], A S Smiline Girija[SUP] 4 [/SUP], Vijayakumar Velu[SUP] 5 6 [/SUP], Abdul W Ansari[SUP] 7 [/SUP], Marie Larsson[SUP] 8 [/SUP]
Affiliations
- PMID: 33537740
- DOI: 10.1093/femspd/ftaa076
Abstract
A vast proportion of coronavirus disease 2019 (COVID-19) individuals remain asymptomatic and can shed severe acute respiratory syndrome (SARS-CoV) type 2 virus to transmit the infection, which also explains the exponential increase in the number of COVID-19 cases globally. Furthermore, the rate of recovery from clinical COVID-19 in certain pockets of the globe is surprisingly high. Based on published reports and available literature, here, we speculated a few immunovirological mechanisms as to why a vast majority of individuals remain asymptomatic similar to exotic animal (bats and pangolins) reservoirs that remain refractile to disease development despite carrying a huge load of diverse insidious viral species, and whether such evolutionary advantage would unveil therapeutic strategies against COVID-19 infection in humans. Understanding the unique mechanisms that exotic animal species employ to achieve viral control, as well as inflammatory regulation, appears to hold key clues to the development of therapeutic versatility against COVID-19.
Keywords: COVID-19; SARS-CoV-2; asymptomatic; evolution; monocytes; origin.